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Human adenoviruses (AdVs) typically cause mild illnesses in otherwise healthy hosts. We investigated a
pediatric outbreak of acute respiratory infection with fatal outcomes that occurred in Lisbon, Portugal, in 2004.
Biological specimens were collected from 83 children attending two nurseries, a kinesiotherapy clinic, and the
household of a nanny. Adenovirus infection was confirmed in 48 children by PCR and virus isolation. Most
(96%) isolates were classified as being of subspecies B1. Phylogenetic analysis of fiber and hexon gene
sequences revealed that most infants were infected with AdV serotype 3 (AdV3) strains. Infants attending one
nursery harbored a new recombinant strain containing an AdV serotype 7 hexon and serotype 3 fiber (AdV7/3).
Both the AdV3 and the AdV7/3 strains caused fatal infections. Two different serotype 3 strains were circulating
in Lisbon in 2004, and the new AdV7/3 recombinant type originated from only one of those strains. These
results demonstrate that recombination leads to the emergence of new adenovirus strains with epidemic and
lethal potential.
Human adenoviruses (HAdVs) have been associated with a
wide spectrum of clinical diseases with respiratory and gastro-
intestinal symptoms (23, 32). Severe illness can occur in new-
borns, elderly individuals, and patients with underlying medical
conditions. In otherwise healthy adults, infections caused by
human adenoviruses do not represent a life-threatening clini-
cal condition. Adenoviruses are characterized by a linear dou-
ble-stranded DNA genome of 2 to 45 kbp that encodes 30 to 40
proteins (6). HAdV comprises 51 serotypes (HAdV-1 to
HAdV-51), on the basis of type-specific antiserum-mediated
neutralization of infectivity (10). The serotypes can be divided
into seven species, named HAdV-A to HAdV-G, on the basis
of hemagglutination inhibition and biochemical criteria (13).
HAdV-B is further classified into subspecies B1 and B2, which
use different cellular receptors for viral entry (29). These vari-
ants can be segregated by different geographic areas, time
periods, and clinical conditions.
Serotype identification is critical for epidemiological surveil-
lance, the detection of new strains, assessment of treatment
efficacy, and understanding the pathogenesis of HAdV. For
example, acute respiratory disease is primarily caused by
HAdV-B1 serotypes 3, 7, 16, and 21; HAdV-B2 serotypes 11
and 14; and HAdV-E serotype 4 (8, 23, 25, 28, 35, 38, 41).
Respiratory infections caused by HAdV-B1 serotypes 3 and 7
(16) and HAdV-B2 serotype 14 (17) are potentially fatal. Neu-
tralization tests are the classical reference method used for the
typing of adenovirus and require virus isolation from infected
organs or tissues (20). The main type-specific neutralizing
epitope, the ε determinant, consists of loop 1 (L1) and loop 2
(L2) on the hexon protein, the major capsid protein and the
most abundant structural protein (26). Cases of the failure of
neutralization with the available antisera require extensive
cross-neutralization studies to define a new HAdV type. To
circumvent the practical problems associated with traditional
serum neutralization studies, molecular methods for the typing
of adenovirus have been established. Examples are restriction
fragment length polymorphism (RFLP) analysis of adenoviral
DNA (16), PCR-based assays (1, 36), and microarray-based
methods (36). However, these methods cannot discriminate
between all serotypes and do not allow detailed studies of
molecular epidemiology and viral evolution to be performed.
More recently, analysis of the nucleotide and amino acid
sequences from different genes has shown that adenovirus spe-
cies form three distinct phylogenetic clusters: HAdV-C be-
longs to cluster 1; HAdV-A and HAdV-F belong to cluster 2;
and HAdV-B, HAdV-D, and HAdV-E belong to cluster 3 (6,
22). In addition, phylogenetic analysis of selected gene frag-
ments has increasingly been used to classify human adenovi-
ruses at the serotype and species levels (7, 19, 40), to detect
cases of coinfection with multiple adenoviral species (36, 38),
and to identify new recombinant strains formed between sim-
ilar species (18, 37, 41) or different species (19). Finally, phy-
* Corresponding author. Mailing address for Nuno Taveira: Un-
idade dos Retrovírus e Infecc¸o˜es Associadas, Centro de Patoge´nese
Molecular, Faculdade de Farma´cia de Lisboa, Avenida das Forc¸as
Armadas, Lisbon 1649-019, Portugal. Phone: 35 121 7946 400. Fax: 35
121 7934 212. E-mail: ntaveira@ff.ul.pt. Mailing address for Helena
Rebelo-de-Andrade: Departamento de Doenc¸as Infecciosas I.P.,
Instituto Nacional de Sau´de, Avenida Padre Cruz, Lisbon 1649-016,
Portugal. Phone: 35 121 7508 159. Fax: 35 121 7526 400. E-mail:
H.Rebelo.Andrade@insa.min-saude.pt.
 Published ahead of print on 10 February 2010.
1391
logenetic analysis has become an important tool in the epide-
miological investigation of many disease outbreaks caused by
adenovirus (11, 17, 27, 40, 41). In the present study, we have
used epidemiological, virological, and molecular phylogenetic
methods to investigate the causes and origin of a recent out-
break of acute respiratory infection in Lisbon, Portugal, that
resulted in the deaths of two children.
MATERIALS AND METHODS
Patients and specimens. Biological specimens were collected during an out-
break of respiratory infection that occurred in Lisbon in 2004 and that mainly
affected children (median age, 17 months; maximum age, 117 months; minimum
age, 0 months) (Table 1). The alert came with the hospitalization of five children
with viral pneumonia with suspicion of an adenoviral etiology; and two of those
children, one female and one male 6 and 20 months of age, respectively, died.
These cases led to an epidemiological investigation focused on infants attend-
ing (i) the nursery of one of the deceased infants (patient PA27, kindergarten A),
(ii) the home of the nanny of the other deceased infant (patient PA22), and (iii)
a respiratory kinesiotherapy clinic attended by the remaining three children.
Later, other biological specimens were collected from children from a second
nursery (kindergarten B) who were also hospitalized. Samples collected from
symptomatic children attending a third nursery (kindergarten C) were used as
controls. During this epidemiological investigation, a total of 128 biological
specimens were collected from 83 children. More precisely, at least one sample
from the respiratory tract (a respiratory secretion and/or nasopharyngeal swab
specimen) and a fecal sample from each child were collected and analyzed.
Postmortem biopsy specimens of the lungs and liver from one of the deceased
children were also studied. All biological specimens (respiratory and fecal sam-
TABLE 1. Epidemiological, clinical, and virological characteristics of HAdV-B-infected infants
Patient Age (mo) Symptomseveritya Place of infection
Serotype
Hexon gene Fiber gene,
phylogenetic
analysis
PCR and
REAb
Phylogenetic
analysis
PA2 14  Kindergarten A 7 7 3
PA3 22  Kindergarten A 7 NDc ND
PA4 17  Kindergarten A 7 ND ND
PA5 23  Kindergarten A 7 ND ND
PA6 21  Kindergarten A 7 7 ND
PA17 27  Kindergarten A 7 7/7d 3
PA23 18  Kindergarten A 7 ND ND
PA27 6  (D) Kindergarten A 7 7/7d 3
PA57 23  Kindergarten A 7 7 3
PA28 6  Kindergarten A 7 ND ND
PA19 NAe 0 Nanny 3 ND ND
PA22 20  (D) Nanny 3 3/3/3/3/3/3/3d 3/3/3/3/3/3/3d
PA25 6  Kindergarten B 3 ND ND
PA32 15 0 Kindergarten B 3 3 3
PA33 21 0 Kindergarten B 3 ND ND
PA35 32 0 Kindergarten B 3 ND ND
PA37 33 0 Kindergarten B 3 ND ND
PA38 53 0 Kindergarten B 3 3 3
PA39 11  Kindergarten B 3 ND ND
PA40 32  Kindergarten B 3 ND ND
PA41 23  Kindergarten B 3 3 ND
PA42 13  Kindergarten B 3 3/3d 3
PA64 7  Kindergarten B 3 3 3
PA65 22  Kindergarten B 3 ND ND
PA77 13 0 Kindergarten B 3 ND ND
PA80 6 0 Kindergarten B 3 ND ND
PA81 4  Kindergarten B 3 ND ND
PA82 5  Kindergarten B 3 ND ND
PA26 13  Kinesiotherapy clinic 3 3 3
PA29 11  Kinesiotherapy clinic 3 3 3
PA30 5  Kinesiotherapy clinic 3 3 3
PA31 3  Kinesiotherapy clinic 3 3 3
PA44 1 0 Kinesiotherapy clinic 3 ND ND
PA46 8 0 Kinesiotherapy clinic 3 ND ND
PA50 16 0 Kinesiotherapy clinic 3 ND ND
PA54 1  Kinesiotherapy clinic 3 ND ND
PA55 4  Kinesiotherapy clinic 3 ND ND
PA56 0  Kinesiotherapy clinic 3 ND ND
PA58 14  Kinesiotherapy clinic 3 ND ND
PA60 9 0 Kinesiotherapy clinic 3 ND ND
PA61 35  Kinesiotherapy clinic 3 ND ND
a 0, no symptoms; , mild symptoms; , moderately severe symptoms; , severe symptoms;  (D), death.
b Results obtained using a general PCR combined with restriction endonuclease analysis.
c ND, not done.
d Results based on sequences from isolates obtained from different tissues.
e NA, data not available.
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ples) were analyzed by PCR, and those positive for adenovirus by PCR (48
specimens) were submitted for virus isolation. Because of the limited amount of
reference serum available, only a subset of 17 samples was evaluated by a
microneutralization assay. These samples were from the 2 deceased children, 3
cases who presented with more severe symptoms and who were close contacts of
kindergarten A, and 12 selected cases from kindergarten B and from the kine-
siotherapy clinic. Forty-one species B-positive specimens were further charac-
terized genetically by PCR-restriction enzyme analysis (REA) of the hexon gene.
The hexon and fiber genes of the isolates from 15 patients who presented with
higher viral loads and for whom the amount of the original specimen was not a
limiting factor were sequenced. Informed consent to participate in the study was
obtained from the parents of the children. The study was reviewed and approved
by the ethics committees of the participating institutions.
Extraction of nucleic acids, PCR amplification, and sequencing. Viral DNA
was extracted from the clinical specimens by a guanidine thiocyanate-silica bind-
ing method adapted from the method of Boom et al. 1990 (3) and was stored at
80°C. On arrival, all specimens were tested for adenovirus infection by an
adenovirus-specific nested PCR (2). All adenoviruses were further subtyped by
multiplex PCR with primers targeting the fiber gene (39). The fiber gene nucle-
otide sequences were obtained by a cycle sequencing reaction with the PCR
primers and a BigDye Terminator kit (Applied Biosystems).
Genetic analysis of the hexon gene was subsequently performed for all species
B-positive samples. PCR-REA was carried out by use of an adaptation of the
protocol described by Allard et al. (1), which used 20 l of viral DNA and 80 l
of a PCR mixture containing 0.5 M each primer, 0.2 M deoxynucleoside
triphosphates, 3 mM MgCl2, 1 U of Taq polymerase, and 10 l of 10 PCR
buffer. Enzymatic digestion was carried out with three enzymes (AcsI, Bsp1286I,
and HinfI) and 10 l of the PCR product under the conditions specified by the
manufacturer. The restriction enzyme digests were loaded onto a 3% agarose gel,
and gel electrophoresis was run for 3 h at 75 V in TBE (Tris-borate-EDTA)
buffer. After staining of the gel with ethidium bromide (1 g/ml), the DNA
fragments were photographed under UV light. For sequencing analysis, part of
the hexon gene was amplified by PCR with the primers and under the conditions
described previously (4, 15, 24). Sequencing was performed with the PCR prim-
ers and a BigDye Terminator kit (Applied Biosystems).
Virus isolation and neutralization assay. All biological specimens with an
adenovirus-positive PCR result were inoculated onto HEp-2, Vero, MRC-5, and
RD cells for virus isolation. The nasopharyngeal swab specimens were previously
treated with 2.0 ml of tryptose supplemented with gelatin and a mix of antibiotics
and an antifungal agent. The fecal samples were diluted in phosphate-buffered
saline (1/5), the mixture was centrifuged, and the supernatant was treated with
chloroform (antibiotics and an antifungal were added). The processed biological
specimens were inoculated into tubes with a confluent monolayer of HEp-2,
Vero, MRC-5, or RD cells. The tubes were incubated at 37°C and observed daily
for a cytopathic effect (CPE; rounded cells). The serotypes of the isolates were
determined by a microneutralization assay with 2-fold dilutions of type-specific
hyperimmune rabbit antisera (anti-type 3, anti-type 4, and anti-type 7) produced
in our laboratory and empirical determination of the virus dosages which induced
a CPE on 100% of the HEp-2 or MRC-5 cells after 7 days of incubation at 37°C
(5, 20). For serotype determination, the highest dilution which completely in-
hibited the development of a CPE (100% neutralization) and the highest dilution
which inhibited 75% of the CPE (75% neutralization) were considered. The
serotype identification was confirmed when the neutralization titer observed was
within 16-fold of the titer observed when the same antiserum was tested against
the homologous prototype virus. Isolates neutralized by both anti-type 7 anti-
serum and anti-type 3 antiserum but not by anti-type 4 antiserum were consid-
ered to present double cross-reactivity.
Phylogenetic analysis. The nucleotide sequences produced in this study were
first compared with all sequences present in GenBank by pairwise alignment by
use of the BLAST program. The 10 sequences with the highest alignment scores
were recovered. Reference genomic sequences of each adenovirus species within
the Mastadenovirus genus were also obtained from GenBank. All sequences were
aligned by using the CLUSTAL X program; the alignments were manually edited
with the GENEDOC program.
For the fiber gene, phylogenetic reconstructions were done with an alignment
of 379 nucleotides of 53 taxa (positions 31379 to 31707 in reference strain
AY599836.1 of HAdV-B1 serotype 3); an alignment of 257 nucleotides of 60 taxa
was performed as used for the hexon gene (positions 18479 to 18734, corre-
sponding to amino acids 22 to 106). Maximum-parsimony and maximum-likeli-
hood analyses with bootstrap analysis (1,000 replicates) were used for inference
of the phylogenetic trees. The nucleotide distances were also calculated for the
hexon and fiber sequences by using the Kimura two-parameter substitution
model with different rates of substitution among sites (the  distribution). The 
shape parameter  was arbitrarily set equal to 1.0. Phylogenetic reconstructions
and nucleotide distances were determined by the use of MEGA (version 4)
software (34).
Nucleotide sequence accession numbers. The sequences determined in this
study have been assigned GenBank accession numbers GQ922009 to GQ922027
(fiber genes) and GQ922028 to GQ922051 (hexon genes).
RESULTS
Adenovirus infection was confirmed using PCR for 48
children up to 36 months of age. Most of the children were
male (62%). Twelve (25%) of 48 infants were from kinder-
garten A, 20 (42%) were from kindergarten B, 3 (6%) were
from the household of the nanny, and 13 (27%) were from
the respiratory kinesiotherapy clinic (Table 1). The adeno-
virus infections were asymptomatic in 17 (35%) infants and
caused mild symptoms in 7 (15%) infants, moderate symp-
toms in 11 (23%) infants, severe symptoms in 11 (23%)
infants, and death in 2 (4%) infants. The deaths occurred in
one child from kindergarten A and one child attending the
household of a nanny (Table 1). By multiplex PCR, 46
(96%) of the positive isolates were classified as HAdV-B,
and the remaining 2 were found to belong to species C and
D. Virus was isolated from at least one specimen per case
studied, resulting in a total of 48 isolates.
Seventeen of the 48 isolates (35%) were subtyped by micro-
neutralization assay. The results revealed that four of the iso-
lates showed double cross-reactivity with AdV serotype 3
(AdV3) and AdV7 antisera. These isolates corresponded to
one isolate from a deceased child (patient PA27) and isolates
from the three contacts from kindergarten A (patients PA2,
PA17, and PA57) (data not shown). Genetic characterization
of 41 virus isolates was first done by restriction enzyme analysis
of the hexon gene (Table 1). It was found that 31 (76%) infants
were infected with serotype 3 viruses and that 10 (24%) were
infected with serotype 7 viruses.
Fifteen isolates were subsequently characterized by se-
quencing and phylogenetic analysis of the fiber gene and/or
the hexon gene. Analysis by maximum parsimony revealed
that all fiber gene sequences (n  14; 100%) were highly
conserved and clustered together within human adenovirus
subspecies B1, serotype 3 (Fig. 1A). For the hexon gene, 10
sequences clustered together within HAdV-B1 serotype 3.
In addition, five sequences from patients PA2, PA6, PA17,
PA27, and PA57 were phylogenetically related to HAdV-B1
serotype 7 virus (Fig. 1B). Similar results were obtained by
maximum-likelihood analysis using different models of nu-
cleotide substitution (data not shown). The discordant phy-
logenies in the hexon and fiber genes of the isolates from
these patients indicate that they harbor a recombinant ad-
enovirus strain containing a chimeric capsid composed of a
serotype 7 hexon protein and a serotype 3 fiber (AdV7/3).
All putative recombinant strains were detected in infants
from kindergarten A (Table 1). One of these children
(PA27) died of acute respiratory disease. The other fatal
infection (PA22) was due to a serotype 3 strain and occurred
at a different location (the home of the nanny).
We also determined the nucleotide evolutionary distances
and the nucleotide and amino acid similarities between the
Portuguese hexon and fiber sequences and compared the
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sequences with those of reference strains. The serotype 3
hexon gene sequences from Portugal differed from the ho-
mologous reference sequences by 1 to 4 (0.4% to 1.6%)
nucleotides. The serotype 7 hexon gene sequences from
Portugal differed from the homologous reference sequences
at only 1 (0.4%) nucleotide, located at position 244 (an A
nucleotide in the reference sequences and a C nucleotide in
the Portuguese sequences). This is a nonsynonymous sub-
stitution that leads to a serine-to-arginine amino acid re-
placement at position 82. In contrast, the serotype 7 Portu-
guese hexon gene sequences differed from the serotype 3
Portuguese hexon gene sequences by 11 (4.3%) residues, all
of which were of a synonymous nature (no amino acid re-
placements occurred). Regarding the nucleotide distances,
the hexon genes of serotype 3 strains were also more diver-
gent than those of the serotype 7 strains (Table 2). As was
the case for the reference sequences, the fiber gene se-
quences from the serotype 3 Portuguese isolates were highly
homologous (Table 3). In fact, only one nucleotide at posi-
tion 93 was variable (synonymous substitution) in more than
one sequence. In all AdV7/3 recombinant strains, the nu-
cleotide at this position was a C (a TTC serine codon),
FIG. 1. Evolutionary relationships of adenovirus isolates. The evolutionary history was inferred by using the maximum-parsimony method and
the nucleotide sequences of the hexon (B) and fiber (A) genes. The percentages of replicate trees in which the associated taxa clustered together
in the bootstrap test (1,000 replicates) are shown below the branches. Only bootstrap values above 70% are shown. The tree is drawn to scale, and
the branch lengths were calculated by using the average pathway method and are in units of the number of changes over the whole sequence.
Reference Mastadenovirus genus strains are indicated in italics and are marked by the GenBank accession number, the name of the host, the
country of origin in International Organization for Standardization characters (CN, China; KR, Republic of Korea; US, United States of America;
CH, Switzerland), and the serotype number. Species names are abbreviated as follows: BAdV, bovine AdV; OAdV, ovine AdV; PAdV, porcine
AdV; CAdV, canine AdV; MAdV, mouse AdV; and TSAdV, tree shrew AdV. S, stool; T and ST, tracheal suction; NF, nasopharyngeal.
Postmortem tissue types: LLS, left lung section; RLS, right lung section; LLI, liver lobe. Sequences from Portuguese patients are indicated in
boldface. Each patient is designated by PA followed by a number. The postmortem tissue used for virus isolation for the deceased patients (patients
PA22 and PA27, also designated †) is indicated. The nucleotide at position 93 in the fiber gene (C or G) is indicated in parentheses (see
Discussion).
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whereas in the serotype 3 strains it was a G (a TTG serine
codon) (Fig. 1A).
DISCUSSION
In this report we describe epidemiological, virological, and
molecular phylogenetic investigations undertaken to identify
the cause and the origin of an outbreak of acute and fatal
respiratory infection that occurred in Lisbon and that involved
48 infants (median age, 17 months).
Using neutralization, restriction enzyme analysis, and/or
phylogenetic analysis of hexon and fiber gene fragments, we
were able to accurately identify serotype 3 of the HAdV-B1
subspecies to be the main causative agent of this outbreak. Our
results confirm and extend previous findings showing that Ad3
and Ad7 are highly virulent and potentially lethal subtypes,
especially for children (8, 12, 16, 25, 38). Sequencing and
phylogenetic analysis indicated that infants from one kinder-
garten were infected with a new recombinant adenovirus strain
composed of a serotype 7 hexon and a serotype 3 fiber. As with
Adv3, the Adv7/3 recombinant strain caused several severe
infections, including one that was fatal. These results demon-
strate that the new AdV7/3 recombinant strain is transmissible,
epidemic, and highly virulent.
Of note, we could not identify the new AdV7/3 recombinant
strain using standard neutralization analysis due to extensive
cross-reactivity with reference anti-type 3 and anti-type 7 sera.
The type-determining neutralizing epitopes are primarily lo-
cated in hexon loop 1 and, to a much lesser degree, loop 2 (4,
9). The results therefore suggest that the AdV7/3 strain has a
chimeric hexon protein that comprises the type-determining
neutralizing epitopes from the original serotype 7 and serotype
3 strains. Sequencing of the entire hexon gene of the recom-
binant strains will need to be done to investigate this possibil-
ity. Nonetheless, our results confirm the limitations of the use
of neutralization-based assays for the serotyping of chimeric
adenovirus strains (9).
The serotype 7 partial hexon gene sequences from Portugal
differed from the homologous reference sequences by 1 amino
acid at position 82 (a serine-to-arginine replacement), and the
fiber gene sequences of the serotype 3 isolates differed from
each other by only 1 nucleotide (at position 93). Remarkably,
in all putative AdV7/3 recombinant strains, the nucleotide at
this position was C, whereas in the serotype 3 strains it was G.
These results confirm the strong genetic relatedness and slow
evolution of these two serotypes (14, 19, 30). On the other
hand, these results show that it is possible to find efficient
molecular epidemiologic markers of the circulating adenovirus
strains involved in disease outbreaks.
The presence of the HAdV-B serotype 7/3 recombinant
strain in the infected infants may have one of two explanations:
coinfection with both serotypes or infection with a new recom-
binant strain. Coinfection with HAdV-4 and HAdV-7 strains
has recently been observed in several patients with acute re-
spiratory disease (36). On the basis of the sequence analysis,
we do not favor this hypothesis because none of the patients in
this outbreak seemed to be infected with HAdV-B subtype 7.
Instead, our results suggest that two different parental subtype
3 strains were circulating in Lisbon in 2004 and that only one
of them gave rise to the new recombinant strain with HAdV-B
serotype 7. The HAdV-B serotype 7/3 recombinant strain must
have been generated in an unidentified index case in the same
year and was readily transmitted to and among the infants of
kindergarten A.
Phylogenetic discordances between the fiber gene and/or the
hexon gene of several human adenoviruses have been docu-
mented before, indicating that intra- and interspecies recom-
bination are relatively frequent events in the evolution of
HAdV (7, 19). However, to our knowledge, this is the first
description in Europe of a HAdV-B serotype 7/3 recombinant
strain causing acute lower respiratory tract infection and death.
A potentially similar recombinant strain was previously found
in South America (1991 to 1994), where it caused 17 of 18 fatal
lower respiratory tract infections in children (12). The wider
transmission of the HAdV-B serotype 7/3 recombinant strains
may have been prevented by its potential to cause death.
Clearly, further studies are needed to better understand the
epidemiology and natural history of these recombinant adeno-
viruses.
Recombination may lead to faster rates of molecular evolu-
tion of human adenoviruses, may increase viral fitness, may
change cell tropism, and, as seen here and elsewhere, may lead
to the generation of new and more virulent strains (12, 21, 31,
33). Recombination is also an important issue for adenovirus-
based vaccine development. Thus, a better understanding of
the impact of recombination in the epidemiology and patho-
genesis of human adenoviruses is urgently required.
In conclusion, human adenovirus serotype 3 and a newly
formed HAdV-B serotype 7/3 recombinant strain were identi-
fied as the prevailing etiological agents of an outbreak of acute
respiratory infection that occurred among young children in
Lisbon in 2004 and that resulted in two deaths. Our data
provide new evidence that recombination drives the generation
TABLE 2. Nucleotide distances between hexon sequences from
Portuguese patients and reference isolatesa
Sequence No. ofpatients
Within-group: Between-group:
Genetic
distance SE
Genetic
distance SE
HAdV3 ref. 12 0.003 0.002 0.002 0.001
HAdV3 PT 11 0.001 0.001
HAdV7 ref. 3 0.000 0.000 0.000 0.000
HAdV7 PT 4 0.000 0.000
a SE, standard error calculated by bootstrap resampling; PT, Portuguese se-
quences (this study); ref., reference sequences (from GenBank).
TABLE 3. Nucleotide distances between fiber sequences from
Portuguese patients and reference isolatesa
Sequence No. ofpatients
Within-group: Between-group:
Genetic
distance SE
Genetic
distance SE
HAdV3 ref. 11 0.002 0.001 0.004 0.004
HAdV3 PT 13 0.002 0.002
HAdV7 ref. 3 0.000 0.000 NA NA
a SE, standard error calculated by bootstrap resampling; PT, Portuguese se-
quences (this study); ref., reference sequences (from GenBank); NA, not appli-
cable.
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of highly virulent human adenovirus strains with epidemic and
lethal potential.
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